$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre Vascular Inc (NASDAQ:LMAT) to Issue Dividend Increase - $0.10 Per Share
12:26pm, Wednesday, 12'th Feb 2020
LeMaitre Vascular Inc (NASDAQ:LMAT) announced a quarterly dividend on Monday, February 10th, Wall Street Journal reports. Shareholders of record on Tuesday, March 3rd will be given a dividend of 0.095
LeMaitre Vascular (NASDAQ:LMAT) Downgraded by BidaskClub to "Sell"
11:52am, Wednesday, 12'th Feb 2020
BidaskClub lowered shares of LeMaitre Vascular (NASDAQ:LMAT) from a hold rating to a sell rating in a research note released on Tuesday morning, BidAskClub reports. Other equities analysts have also r
LabCorp (LH) Rides on Solid Diagnostics Despite PAMA Issues
03:41pm, Tuesday, 11'th Feb 2020
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
LabCorp (LH) Rides on Solid Diagnostics Despite PAMA Issues
03:41pm, Tuesday, 11'th Feb 2020
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
Edited Transcript of LMAT earnings conference call or presentation 6-Feb-20 10:00pm GMT
01:39pm, Tuesday, 11'th Feb 2020
Q4 2019 LeMaitre Vascular Inc Earnings Call
Here's Why You Should Add Zimmer (ZBH) to Your Portfolio
02:28pm, Monday, 10'th Feb 2020
Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.
Hologic Expands Panther Portfolio With New Product Offerings
01:34pm, Monday, 10'th Feb 2020
Hologic's (HOLX) latest offerings are set to improve flexibility and efficiency of laboratories.
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2020 After-Hours Earnings Guidance
04:50am, Monday, 10'th Feb 2020
LeMaitre Vascular (NASDAQ:LMAT) updated its FY 2020 After-Hours earnings guidance on Thursday. The company provided EPS guidance of 0.90-0.98 for the period, compared to the Thomson Reuters consensus
LeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
01:42pm, Sunday, 09'th Feb 2020
There's been a notable change in appetite for LeMaitre Vascular, Inc. (NASDAQ:LMAT) shares in the week since its...
Lemaitre Vascular (LMAT) Gets a Buy Rating from Barrington
03:01pm, Friday, 07'th Feb 2020
Barrington analyst Michael Petusky maintained a Buy rating on Lemaitre Vascular (LMAT) today and set a price target of $38.00. The company's shares closed
Lemaitre Vascular (LMAT) Gets a Buy Rating from Barrington
03:01pm, Friday, 07'th Feb 2020
Barrington analyst
Michael Petusky
maintained a
Buy
rating on Lemaitre Vascular (
LMAT
–
Research Report
) today and set a price target of
$38.00
. The company’s shares closed last Monday at $32.1
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Sign In
Buy LMAT